| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/27/2011 | EP2346819A1 Naphthylacetic acids |
| 07/27/2011 | EP2346514A1 Medium derived from stem cells as a pharmaceutical composition |
| 07/27/2011 | EP2346504A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 07/27/2011 | EP1992622B1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 07/27/2011 | EP1878738B1 1-kestose for treating allergy and atopic dermatitis |
| 07/27/2011 | EP1845780B1 Uses of methylphenidate derivatives |
| 07/27/2011 | EP1841780B1 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 07/27/2011 | EP1682135B1 salt of a tetrahydropyranyl cyclopentyl tetrahydropyridopyridine derivative as CCR2-antagonist |
| 07/27/2011 | EP1638964B1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/27/2011 | EP1633396B1 Cd20 binding molecules |
| 07/27/2011 | EP1558645B1 Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| 07/27/2011 | EP1490355B1 Indolylmaleimide derivatives |
| 07/27/2011 | EP1474415B1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1389616B1 3,4-Dihalobenzylpiperidine derivatives and their medical use |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/27/2011 | CN1968708B Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 07/27/2011 | CN102137848A 2,4-diaminopyrimidine compound |
| 07/27/2011 | CN102134609A Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 07/27/2011 | CN102134284A Anti-hepatoma drug strongylocentrotus nudus egg polysaccharide SEP-1 based on immune regulation |
| 07/27/2011 | CN102134269A Nitrooxy derivatives of glucocorticoids |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134215A Derivative of Fexofenadine and composite and application thereof |
| 07/27/2011 | CN102133418A Effective aromatherapy piece made from flos chrysanthemi indici bud and preparation method thereof |
| 07/27/2011 | CN102133410A Immunotherapy of B cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
| 07/27/2011 | CN102133389A Disinfectant traditional Chinese medicine for livestock and poultry |
| 07/27/2011 | CN102133308A Capsule for removing toxin and eliminating fat |
| 07/27/2011 | CN102133305A Composite of health-care matters or medicines used for improving immunity and preventing 'three high' and application thereof |
| 07/27/2011 | CN102133300A Chinese medicine composition with function of immunological enhancement and application thereof |
| 07/27/2011 | CN102133298A Two-aqueous-phase method for extracting total saponin from bittersweet herb |
| 07/27/2011 | CN102133289A Particle for protecting liver and beautifying skin |
| 07/27/2011 | CN102133281A Edible fungi health care pill |
| 07/27/2011 | CN102133278A Preparation method of 98% of paeoniflorin radix in radix paeoniae alba extract |
| 07/27/2011 | CN102133252A Preparation method of footbath agent rich in selenium and chromium |
| 07/27/2011 | CN102133250A Medicinal composition with effect of improving immunity |
| 07/27/2011 | CN102133249A Medicine composite with effect of improving immunity |
| 07/27/2011 | CN102133241A Medicine composite with effect of improving immunity |
| 07/27/2011 | CN102133237A Propolis flavone soft capsule and preparation method thereof |
| 07/27/2011 | CN102133232A Cobra venom physical modification method and application in preparation of analgesia or immunosuppressive drugs |
| 07/27/2011 | CN102133179A Stable cetirizine oral solution |
| 07/27/2011 | CN102133018A Health care drug pillow |
| 07/27/2011 | CN102132952A Folium cortex eucommiae common melastoma herb cigarette and preparation method thereof |
| 07/27/2011 | CN102132873A Medicine or health-care food for supplementing blood and regulating immunity |
| 07/27/2011 | CN101843616B Composition of fexofenadine hydrochloride and microcrystalline cellulose and preparation method thereof |
| 07/27/2011 | CN101744985B Medicament for treating child repetitive respiratory infection and low immunity |
| 07/27/2011 | CN101721492B Fluorescent scanning quantitative determination method for non-fluorescent compound paeonolum |
| 07/27/2011 | CN101690813B Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof |
| 07/27/2011 | CN101623326B Sculellaria barbata formulation and preparation method thereof |
| 07/27/2011 | CN101623265B Production process for dexamethasone sodium phosphate bulk medicament |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101474246B Pharmaceutical composition for enhancing immunity of fowl and coordinating with vaccine for synergy |
| 07/27/2011 | CN101367716B Carbon shell bacterium polyketone, preparation and uses thereof |
| 07/27/2011 | CN101357130B Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride |
| 07/27/2011 | CN101306018B Hyper-concentrated placenta tissue hydrolysate freeze-drying capsules and its preparation method |
| 07/27/2011 | CN101249259B High content and high activity oral polysaccharide-peptide and preparing method and application of the same |
| 07/27/2011 | CN101244235B Scraping oil, preparation method and application thereof |
| 07/27/2011 | CN101242849B Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis |
| 07/27/2011 | CN101180050B Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 07/27/2011 | CN101067146B Biological extraction process of glycyrrhizic acid |
| 07/27/2011 | CN101062949B Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 07/26/2011 | CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
| 07/26/2011 | CA2222757C Modified/chimeric superantigens and their use |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011087776A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 07/21/2011 | WO2011087637A1 Stem cell immune modulation methods of use and apparatus |
| 07/21/2011 | WO2011087102A1 Therapeutic agent for promoting recovery of animal under medical treatment |
| 07/21/2011 | WO2011086085A1 Thiazole and oxazole kinase inhibitors |
| 07/21/2011 | WO2011086053A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| 07/21/2011 | WO2011085653A1 Method and kit for identifying and treating graves' disease |
| 07/21/2011 | WO2011085574A1 Complete human anti-tnf-alpha monoclonal antibodies, and manufacturing methods and uses thereof |
| 07/21/2011 | WO2011066342A3 Simultaneous inhibition of pd-l1/pd-l2 |
| 07/21/2011 | WO2011065867A3 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 07/21/2011 | WO2011049291A3 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfβ, and uses thereof |
| 07/21/2011 | WO2011035018A3 Suicide ready cells |
| 07/21/2011 | WO2011008947A3 Treatment and diagnosis of immune disorders |
| 07/21/2011 | US20110178277 Stabilized single domain antibodies |
| 07/21/2011 | US20110178116 Methods of stimulating immune response in certain individuals |
| 07/21/2011 | US20110178099 Pharmaceutical combination |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178063 Benzpyrazol derivatives as inhibitors of pi3 kinases |
| 07/21/2011 | US20110178056 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 07/21/2011 | US20110178034 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 07/21/2011 | US20110178016 Pulse parathyroid hormone for treatment of the hematopoietic syndrome, stromal cell loss, and vascular injury resulting from acute exposure to lethal radiation |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 07/21/2011 | US20110177128 Immunotherapy compositions and methods of treatment |
| 07/21/2011 | US20110177126 Bacteria and derived products to reinforce the body defences and to reduce the risk of disease |
| 07/21/2011 | US20110177124 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/21/2011 | US20110177121 Immunogenic Influenza Composition |
| 07/21/2011 | US20110177120 Mycobacterium tuberculosis vaccine |
| 07/21/2011 | US20110177118 Non-Simian Cells for Growth of Porcine Reproductive and Respiratory Syndrome (PRRS) Virus |
| 07/21/2011 | US20110177117 Chimeric respiratory syncytial virus polypeptide antigens |
| 07/21/2011 | US20110177116 Methods of Immunizing Pregnant Heifers at Three Months of Gestation |
| 07/21/2011 | US20110177115 Vaccination regimen |